【结 构 式】 |
【分子编号】15929 【品名】(3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one 【CA登记号】 |
【 分 子 式 】C10H12N2O 【 分 子 量 】176.21816 【元素组成】C 68.16% H 6.86% N 15.9% O 9.08% |
合成路线1
该中间体在本合成路线中的序号:(IV)A synthesis of L-692429 has been reported: The cyclization of isobutene (I) with chlorosulfonyl isocyanate (II) gives 1-(chlorosulfonyl)-4,4-dimethylazetidin-2-one (III), which is condensed with 3(R)-amino-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one (IV) by means of triethylamine in methanol to yield 3-methyl-3-(methylsulfonamido)-N-[2-oxo-2,3,4,5-tetrahydro-1H-1-benzaze pin-3(R)-yl]butyramide (V). The reaction of (V) with 2'-[1-(triphenylmethyl)tetrazol-5-yl]biphenyl-4-ylmethyl bromide (VI) by means of NaH in THF/DMF affords protected L-692429, which is finally deprotected by a treatment with 5N HCl.
【1】 Bergan, J.J.; Reider, P.J.; McNamara, J.M.; Volante, R.P.; Bhupathy, M.; A convergent synthesis of a novel non-peptidyl growth hormone secretagogue, L-692,429. Tetrahedron Lett 1995, 36, 52, 9445. |
【2】 Schoen, W.R.; et al.; A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429). J Med Chem 1994, 37, 7, 897. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 15926 | 2-methyl-1-propene; isobutylene | 115-11-7 | C4H8 | 详情 | 详情 |
(II) | 14101 | Chlorosulfonyl isocyanate | 1189-71-5 | CClNO3S | 详情 | 详情 |
(III) | 15928 | 2,2-dimethyl-4-oxo-1-azetanesulfonyl chloride | C5H8ClNO3S | 详情 | 详情 | |
(IV) | 15929 | (3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one | C10H12N2O | 详情 | 详情 | |
(V) | 15930 | 3-methyl-3-[(methylsulfonyl)amino]-N-[(3R)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]butanamide | C16H23N3O4S | 详情 | 详情 | |
(VI) | 15538 | 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole | 124750-51-2 | C33H25BrN4 | 详情 | 详情 |
(VII) | 15932 | 3-methyl-3-[(methylsulfonyl)amino]-N-((3R)-2-oxo-1-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)butanamide | C49H47N7O4S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XIV)The selective monoesterification of 2,2-dimethylsuccinic acid (VIII) with methanol and sulfuric acid gives 2,2-dimethylsuccinic acid 4-methyl ester (IX), which is submitted to degradation with diphenylphosphoryl azide, TEA and benzyl alcohol in refluxing benzene, yielding 3-(benzyloxycarbonylamino)-3-methylbutyric acid methyl ester (X). The hydrolysis of (X) with NaOH in methanol affords the corresponding butyric acid (XI). The hydrogenation of 3-azido-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one (XII) with H2 over Pt/C in methanol gives the racemic 3-amino derivative (XIII), which is submitted to optical resolution by crystallization of the L-tartrate salt, yielding the 3(R)-amino derivative (XIV). The condensation of amine (XIV) with acid (XI) by means of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BTPF) and DIEA in dichloromethane affords the corresponding amide (XV), which is condensed with the tetrazole derivative (VII) by means of NaH in DMF to provide the protected adduct (XVI). Finally, this compound is deprotected by hydrogenation with H2 over Pd/C in methanol and a treatment with TFA.
【1】 Watthey, J.W.; et al.; Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme. J Med Chem 1985, 28, 10, 1511. |
【2】 Fisher, M.H.; Wyvratt, M.J.; Schoen, W.R.; DeVita, R.J. (Merck & Co., Inc.); Benzo-fused lactams promote release of growth hormone. EP 0513974; JP 1994172316; US 5206235; WO 9216524 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 15538 | 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole | 124750-51-2 | C33H25BrN4 | 详情 | 详情 |
(VIII) | 46622 | 2,2-dimethylsuccinic acid | C6H10O4 | 详情 | 详情 | |
(IX) | 46623 | 4-methoxy-2,2-dimethyl-4-oxobutyric acid | C7H12O4 | 详情 | 详情 | |
(X) | 46624 | methyl 3-[[(benzyloxy)carbonyl]amino]-3-methylbutanoate | C14H19NO4 | 详情 | 详情 | |
(XI) | 46625 | 3-[[(benzyloxy)carbonyl]amino]-3-methylbutyric acid | C13H17NO4 | 详情 | 详情 | |
(XII) | 20891 | 3-azido-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one | C10H10N4O | 详情 | 详情 | |
(XIII) | 46628 | 3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one | C10H12N2O | 详情 | 详情 | |
(XIV) | 15929 | (3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one | C10H12N2O | 详情 | 详情 | |
(XV) | 46626 | benzyl 1,1-dimethyl-3-oxo-3-[[(3R)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]propylcarbamate | C23H27N3O4 | 详情 | 详情 | |
(XVI) | 46627 | benzyl 1,1-dimethyl-3-oxo-3-[((3R)-2-oxo-1-[[2'-(2-trityl-2H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)amino]propylcarbamate | C56H51N7O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(IX)4-Bromobenzyl alcohol (I) was protected as the silyl ether (II) by treatment with tert-butylchlorodiphenylsilane (TBDPSCl) and Et3N in DMF. Treatment of (II) with BuLi in THF at -78 C, followed by reaction with triisopropyl borate and acid hydrolysis afforded boronic acid (III). Palladium catalyzed coupling of (III) with N-Boc-2-bromobenzylamine (V) (obtained by reaction of 2-bromobenzylamine (IV) with di-tert-butyl dicarbonate), provided biphenyl (VI). This was desilylated by treatment with tetrabutyl ammonium fluoride in THF, and the resulting benzyl alcohol (VII) was converted to mesylate (VIII) with methanesulfonyl chloride and Et3N in CH2Cl2 at 0 C. Coupling of (R)-3-aminobenzazepinone (IX) with N-benzyloxycarbonyl-2-methylalanine (X) using benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) gave amide (XI). Then, regioselective alkylation of (XI) with mesylate (VIII) in the presence of NaH in DMF at low temperature afforded (XII). Subsequent removal of the tert-butoxycarbonyl protecting group with HCl at r.t. yielded amine hydrochloride (XIII), which was condensed with methyl isocyanate to afford urea (XIV). Finally, the N-benzyloxycarbonyl group was removed by hydrogenolysis in the presence of Pd(OH)2 to furnish the title compound.
【1】 A potent, orally bioavailable benzazepinone growth hormone secretagogue. J Med Chem 1998, 41, 10, 1716. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19121 | (4-bromophenyl)methanol | 873-75-6 | C7H7BrO | 详情 | 详情 |
(II) | 19122 | [(4-bromobenzyl)oxy](tert-butyl)diphenylsilane; 4-bromobenzyl tert-butyl(diphenyl)silyl ether | C23H25BrOSi | 详情 | 详情 | |
(III) | 19123 | 4-([[tert-butyl(diphenyl)silyl]oxy]methyl)phenylboronic acid | C23H27BO3Si | 详情 | 详情 | |
(IV) | 19124 | (2-bromophenyl)methanamine; 2-bromobenzylamine | 3959-05-5 | C7H8BrN | 详情 | 详情 |
(V) | 19125 | tert-butyl 2-bromobenzylcarbamate | C12H16BrNO2 | 详情 | 详情 | |
(VI) | 19126 | tert-butyl [4'-([[tert-butyl(diphenyl)silyl]oxy]methyl)[1,1'-biphenyl]-2-yl]methylcarbamate; 2-[[(tert-butoxycarbonyl)amino]methyl]-4'-([[tert-butyl(diphenyl)silyl]oxy]methyl)-1,1'-biphenyl | C35H41NO3Si | 详情 | 详情 | |
(VII) | 19127 | 2-[[(tert-butoxycarbonyl)amino]methyl]-4'-(hydroxymethyl)-1,1'-biphenyl; tert-butyl [4'-(hydroxymethyl)[1,1'-biphenyl]-2-yl]methylcarbamate | C19H23NO3 | 详情 | 详情 | |
(VIII) | 19128 | (2'-[[(tert-butoxycarbonyl)amino]methyl][1,1'-biphenyl]-4-yl)methyl methanesulfonate | C20H25NO5S | 详情 | 详情 | |
(IX) | 15929 | (3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one | C10H12N2O | 详情 | 详情 | |
(X) | 19130 | N-[(benzyloxy)carbonyl]-2-methylalanine | 15030-72-5 | C12H15NO4 | 详情 | 详情 |
(XI) | 19131 | benzyl 1,1-dimethyl-2-oxo-2-[[(3R)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]ethylcarbamate | C22H25N3O4 | 详情 | 详情 | |
(XII) | 19132 | benzyl 2-([(3R)-1-[(2'-[[(tert-butoxycarbonyl)amino]methyl][1,1'-biphenyl]-4-yl)methyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino)-1,1-dimethyl-2-oxoethylcarbamate | C41H46N4O6 | 详情 | 详情 | |
(XIII) | 19133 | benzyl 2-[((3R)-1-[[2'-(aminomethyl)[1,1'-biphenyl]-4-yl]methyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)amino]-1,1-dimethyl-2-oxoethylcarbamate hydrochloride | C36H39ClN4O4 | 详情 | 详情 | |
(XIV) | 19134 | benzyl 1,1-dimethyl-2-[((3R)-1-[[2'-([[(methylamino)carbonyl]amino]methyl)[1,1'-biphenyl]-4-yl]methyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)amino]-2-oxoethylcarbamate | C38H41N5O5 | 详情 | 详情 |